Repozytorium

Nanoscale Ruthenium(III) Complexes with Bioactive Ligands: Structural, Colloidal, and Dual Antimicrobial–Cytotoxic Investigations

Autorzy

Olga Impert

Natalia Czerniecka

Natalia Balińska

Barbara Kubiak

Anna Kozakiewicz-Piekarz

Oleksandra Pryshchepa

Paweł Pomastowski

Michalina Ehlert

Maciej Witwicki

Yogeswara Rao Pateda

Erik Rakovský

Anna Katafias

Rudi van Eldik

Rok wydania

2025

Czasopismo

Dalton Transactions

Numer woluminu

54

Strony

14304-14321

DOI

10.1039/d5dt01857a

Kolekcja

Naukowa

Język

Angielski

Typ publikacji

Artykuł

Streszczenie

This study comprehensively analyses two new ruthenium(III) complexes, [RuIIICl4(Nic)2][(CH3)2NH2]+DMF, 1, and [RuIIICl2(3-HPA)2][3-HH2PA]+(EtOH)22, (where Nic = nicotinic acid (vitamin B3), 3-HPA = anion of a 3-hydroxypicolinic acid), as potential antimicrobial agents, highlighting their physicochemical properties, nanoparticle formation, and cytotoxic activity. The complexes were fully characterised by a single crystal X-ray diffraction technique, Fourier-transform infrared, energy-dispersive X-ray, and electron paramagnetic resonance spectroscopies. The synthesis of micro- and nanoparticles (NPs) of these complexes was performed using the liquid anti-solvent crystallisation method. The formation of NPs was confirmed, and their sizes were determined using scanning electron microscopy and dynamic light scattering techniques. The Debye-Scherrer technique, based on powder diffraction X-ray data, indicated the high crystallinity of the nanomaterials. Toxicity and morphological effects on L929 fibroblasts, hepatocellular carcinoma (Hep-G2) and human epithelial colorectal adenocarcinoma (Caco-2) cell lines of the complexes were assessed using the MTT assay and an inverted phase-contrast microscope, respectively. Complex 1 is a promising anti-cancer drug candidate targeting intestinal cancers, showing cytotoxicity against Caco-2 cancer cells and no cytotoxicity against L929 fibroblast cells, while complex 2 is markedly cytotoxic. The antibacterial activity of the complexes was assessed against methicillin-resistant Staphylococcus aureus (MRSA) and Klebsiella pneumoniae strains using the minimum inhibitory concentration (MIC) method. Complex 2 demonstrates superior bactericidal properties, achieving MIC values as low as 125 μg ml−1 for S. aureus, while complex 1 exhibits lower antimicrobial efficacy. The role of ligand composition in modulating bioactivity was examined.

Licencja otwartego dostępu

CC-BY

Licencja na prawach której można swobodnie kopiować, rozprowadzać, zmieniać i remiksować objęty prawem autorskim utwór (Utwór-przedmiot prawa autorskiego) pod warunkiem podania imienia i nazwiska autora utworu pierwotnego oraz źródła pochodzenia utworu.

Pełny tekst licencji: https://creativecommons.org/licenses/by/3.0/pl/legalcode

Adres publiczny

http://dx.doi.org/10.1039/D5DT01857A

Strona internetowa wydawcy

https://www.rsc.org/

Podobne publikacje